Alan Katz, MD, JD

Disclosure:
No relationships to disclose.

Presentation(s):

• SU_28_2284 - Management of Unfavorable Intermediate and High Risk Prostate Cancer with Stereotactic Body Radiation Therapy as Monotherapy Versus Boost: A Ten Year Study

  Sunday, October 21
  1:15 PM – 2:45 PM

• 59 - Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Ten Year Study

  Monday, October 22
  7:45 AM – 7:55 AM